Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416578779> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2416578779 endingPage "4" @default.
- W2416578779 startingPage "353" @default.
- W2416578779 abstract "Gemcitabine hydrochloride, a pyrimidine antimetabolite, recently was approved as first-line therapy for patients with locally advanced or metastatic adenocarcinoma of the pancreas. This agent also is indicated for use by patients previously treated with 5-FU. Using a new system to measure improvement in disease-related symptoms, two key clinical trials have demonstrated significant clinical benefit responses and a favorable adverse effect profile in patients receiving gemcitabine. With additional experience, the role of gemcitabine in pancreatic cancer, alone or in combination with other antineoplastic agents, will be defined further. The activity of gemicitabine against other malignancies such as ovarian, breast, bladder, small-cell and non-small-cell lung cancers also is being investigated actively." @default.
- W2416578779 created "2016-06-24" @default.
- W2416578779 creator A5037756652 @default.
- W2416578779 date "1996-11-01" @default.
- W2416578779 modified "2023-10-03" @default.
- W2416578779 title "Gemcitabine. New first-line therapy for pancreatic cancer." @default.
- W2416578779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9128490" @default.
- W2416578779 hasPublicationYear "1996" @default.
- W2416578779 type Work @default.
- W2416578779 sameAs 2416578779 @default.
- W2416578779 citedByCount "7" @default.
- W2416578779 countsByYear W24165787792015 @default.
- W2416578779 countsByYear W24165787792016 @default.
- W2416578779 countsByYear W24165787792019 @default.
- W2416578779 countsByYear W24165787792021 @default.
- W2416578779 crossrefType "journal-article" @default.
- W2416578779 hasAuthorship W2416578779A5037756652 @default.
- W2416578779 hasConcept C121608353 @default.
- W2416578779 hasConcept C126322002 @default.
- W2416578779 hasConcept C143998085 @default.
- W2416578779 hasConcept C197934379 @default.
- W2416578779 hasConcept C2778397455 @default.
- W2416578779 hasConcept C2780210213 @default.
- W2416578779 hasConcept C2780258809 @default.
- W2416578779 hasConcept C2781182431 @default.
- W2416578779 hasConcept C535046627 @default.
- W2416578779 hasConcept C71924100 @default.
- W2416578779 hasConceptScore W2416578779C121608353 @default.
- W2416578779 hasConceptScore W2416578779C126322002 @default.
- W2416578779 hasConceptScore W2416578779C143998085 @default.
- W2416578779 hasConceptScore W2416578779C197934379 @default.
- W2416578779 hasConceptScore W2416578779C2778397455 @default.
- W2416578779 hasConceptScore W2416578779C2780210213 @default.
- W2416578779 hasConceptScore W2416578779C2780258809 @default.
- W2416578779 hasConceptScore W2416578779C2781182431 @default.
- W2416578779 hasConceptScore W2416578779C535046627 @default.
- W2416578779 hasConceptScore W2416578779C71924100 @default.
- W2416578779 hasIssue "6" @default.
- W2416578779 hasLocation W24165787791 @default.
- W2416578779 hasOpenAccess W2416578779 @default.
- W2416578779 hasPrimaryLocation W24165787791 @default.
- W2416578779 hasRelatedWork W1906411879 @default.
- W2416578779 hasRelatedWork W2002483815 @default.
- W2416578779 hasRelatedWork W2182918865 @default.
- W2416578779 hasRelatedWork W2271971696 @default.
- W2416578779 hasRelatedWork W2339772723 @default.
- W2416578779 hasRelatedWork W2403481407 @default.
- W2416578779 hasRelatedWork W2415684853 @default.
- W2416578779 hasRelatedWork W2416578779 @default.
- W2416578779 hasRelatedWork W4245839314 @default.
- W2416578779 hasRelatedWork W2780792851 @default.
- W2416578779 hasVolume "4" @default.
- W2416578779 isParatext "false" @default.
- W2416578779 isRetracted "false" @default.
- W2416578779 magId "2416578779" @default.
- W2416578779 workType "article" @default.